en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
U.S. – New Jersey
Solid State Research & Preformulation
500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512
+1 (925) 558-5040

bd_global@crystalpharmatech.com

U.S. – New Jersey
Biologics Characterization and CMC Analytics
Nucleic Acid Solutions (NAX)
2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512
+1 (925) 558-5040

bd_global@crystalpharmatech.com

U.S. – California
Bioanalysis and Biomarker Services, QCP
7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
+1 (925) 351-6210

bd_global@crystalpharmatech.com


Canada – Toronto
Formulation Development & GMP Manufacturing
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
+1 (925) 558-5040

bd_global@crystalpharmatech.com

China – Suzhou
Solid State Research & Preformulation
Nucleic Acid Solutions (NAX)
288 Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123
+86-512-69561921/69561923
+86-512-69561922

contact@crystalpharmatech.com

China – Suzhou
Formulation Development & GMP Manufacturing
Crystal Formulation Services Co., Ltd.
Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123
+86-512-69561921/69561923
+86-512-69561922

contact@crystalpharmatech.com

Achieve Your Success with Our Expertise
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap